RAMIPRIL IN THERAPY OF PATIENTS AFTER MYOCARDIAL INFARCTION

Angiotensin converting enzyme inhibitors are the first line medicine for the treatment of the most of cardiovascular diseases. There is no class-effect for these drugs in myocardial infarction therapy. Moreover in myocardial infarction angiotensin converting enzyme inhibitors have significant intra-...

Full description

Bibliographic Details
Main Authors: I. V. Szirov, E. V. Malichenko
Format: Article
Language:English
Published: Столичная издательская компания 2015-12-01
Series:Рациональная фармакотерапия в кардиологии
Subjects:
Online Access:https://www.rpcardio.online/jour/article/view/510